Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL

Disease Markers

Volumn 28, Issue 6, 2010, Pages 353-360

  Erbilgin, Yucel ^a   Sayitoglu, Muge ^a   Hatirnaz, Ozden ^a   Dogru, Omer ^a   Akcay, Arzu ^b,c   Tuysuz, Gulen ^b,c   Celkan, Tiraje ^a   Aydogan, Gonul ^b,c   Salcioglu, Zafer ^b,c   Timur, Cetin ^c,d   Yuksel Soycand, Lebriz ^c   Uref, Umit ^e   Anakg, Sema ^a   Agaoglu, Leyla ^a   Devecioglu, Omer ^a   Yildiz, Inci ^a   Ozbek, Ugur ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Bakirkoy Maternity and Childrens Hospital ^*  (Turkey)

^c Turkish BFM Study Group   (Turkey)

^d Department of Nuclear Medicine   (Turkey)

^e HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

FBXW7; Mutation; NOTCH1; Prognosis; T ALL

Indexed keywords

CELL CYCLE PROTEIN; F BOX PROTEIN; FBXW7 PROTEIN, HUMAN; MESSENGER RNA; NOTCH1 PROTEIN, HUMAN; NOTCH1 RECEPTOR; RNA; UBIQUITIN PROTEIN LIGASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; FEMALE; GENETICS; HUMAN; INFANT; MALE; MUTATION; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE;

ADOLESCENT; CELL CYCLE PROTEINS; CHILD; CHILD, PRESCHOOL; F-BOX PROTEINS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECEPTOR, NOTCH1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SURVIVAL RATE; UBIQUITIN-PROTEIN LIGASES;

EID: 78149486312     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2010-0715     Document Type: Article

References (55)

1. L. Annino, M.L. Vegna et al., Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study, Blood 99 (2002), 863-871.
2. A.A. Ferrando, D.S. Neuberg et al., Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia, Cancer Cell 1 (2002), 75-87.
3. C. Grabher, H. von Boehmer et al., Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia, Nat Rev Cancer 6 (2006), 347-359.
4. C.H. Pui, M.V. Relling et al., Acute lymphoblastic leukemia, N Engl J Med 350 (2004), 1535-1548.
5. X. Thomas, J.M. Boiron et al., Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial, J Clin Oncol 22 (2004), 4075-4086.
6. C. Linker, L. Damon et al., Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia, J Clin Oncol 20 (2002), 2464-2671.
7. M. Hunault, J.L. Harousseau et al., Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial, Blood 104 (2004), 3028-3037.
8. S.A. Armstrong and A.T. Look, Molecular genetics of acute lymphoblastic leukemia, J Clin Oncol 23 (2005), 6306-6015.
9. J. Aster, W. Pear et al., Functional analysis of the TAN-1 gene, a human homolog of Drosophila notch, Cold Spring Harb Symp Quant Biol 59 (1994), 125-136.
10. S. Artavanis-Tsakonas, M.D. Rand et al., Notch signaling: cell fate control and signal integration in development, Science 284 (1999), 770-776.yx
11. A.Wilson, H.R. MacDonald et al., Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus, J Exp Med 194 (2001), 1003-1012.
12. A.P. Weng, A.A. Ferrando et al., Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia, Science 306 (2004), 269-271.
13. S. Stylianou, R.B. Clarke et al., Aberrant activation of notch signaling in human breast cancer, Cancer Res 66 (2006), 1517-1525.
14. J. Dai, D.Ma et al., Cross-Talk Between Notch and EGFR Signaling in Human Breast Cancer Cells, Cancer Invest (2009), 1.
15. F. Enlund, A. Behboudi et al., Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin’s tumors, Exp Cell Res 292 (2004), 21-28.
16. M. Reedijk, S. Odorcic et al., Activation of Notch signaling in human colon adenocarcinoma, Int J Oncol 33 (2008), 1223-1229.
17. M. Kraman and B. McCright, Functional conservation of Notch1 and Notch2 intracellular domains, Faseb J 19 (2005), 1311-1313.
18. S.J. Bray, Notch signalling: a simple pathway becomes complex, Nat Rev Mol Cell Biol 7 (2006), 678-689.
19. R.P. Hasserjian, J.C. Aster et al., Modulated expression of notch1 during thymocyte development, Blood 88 (1996), 970-976.
20. F. Schweisguth and J.W. Posakony, Suppressor of Hairless, the Drosophila homolog of the mouse recombination signalbinding protein gene, controls sensory organ cell fates, Cell 69 (1992), 1199-1212.
21. M.E. Fortini and S. Artavanis-Tsakonas, The suppressor of hairless protein participates in notch receptor signaling, Cell 79 (1994), 273-282.
22. S. Jarriault, C. Brou et al., Signalling downstream of activated mammalian Notch, Nature 377 (1995), 355-358.
23. C. Sanchez-Irizarry, A.C. Carpenter et al., Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats, Mol Cell Biol 24 (2004), 9265-9273.
24. M.J. Malecki, C. Sanchez-Irizarry et al., Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes, Mol Cell Biol 26 (2006), 4642-4651.
25. C.J. Fryer, J.B. White et al., Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover, Mol Cell 16 (2004), 509-520.
26. K.I. Nakayama and K. Nakayama, Regulation of the cell cycle by SCF-type ubiquitin ligases, Semin Cell Dev Biol 16 (2005), 323-333.
27. C. Oberg, J. Li et al., The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog, J Biol Chem 276 (2001), 35847-35853.
28. H. Rajagopalan, P.V. Jallepalli et al., Inactivation of hCDC4 can cause chromosomal instability, Nature 428 (2004), 77-81.
29. C.H. Spruck, H. Strohmaier et al., hCDC4 gene mutations in endometrial cancer, Cancer Res 62 (2002), 4535-4539.
30. A. Malyukova, T. Dohda et al., The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling, Cancer Res 67 (2007), 5611-5616.
31. W.D. Ludwig, H. Rieder et al., Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89, Blood 92 (1998), 1898-1909.
32. U. Ozbek, A. Kandilci et al., SET-CAN, the product of the t(9;9) in acute undifferentiated leukemia, causes expansion of early hematopoietic progenitors and hyperproliferation of stomach mucosa in transgenic mice, Am J Pathol 171 (2007), 654-666.
33. J. O’Neil, J. Grim et al., FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gammasecretase inhibitors, J Exp Med 204 (2007), 1813-1824.
34. E.S. Antonarakis, J.R. Sampson et al., Temperature modulation of DHPLC analysis for detection of coexisting constitutional and mosaic sequence variants in TSC2, J Biochem Biophys Methods 51 (2002), 161-164.
35. P. Emmerson, J. Maynard et al., Characterizing mutations in samples with low-level mosaicism by collection and analysis of DHPLC fractionated heteroduplexes, Hum Mutat 21 (2003), 112-115.
36. J.K.Wolford, D. Blunt et al., High-throughput SNP detection by usingDNApooling and denaturing high performance liquid chromatography (DHPLC), Hum Genet 107 (2000), 483-487.
37. M.Y. Chiang, M.L. Xu et al., Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1, Mol Cell Biol 26 (2006), 6261-6271.
38. S. Breit, M. Stanulla et al., Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia, Blood 108 (2006), 1151-1157.
39. J.C. Aster, L. Xu et al., Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1, Mol Cell Biol 20 (2000), 7505-7515.
40. C.D. Hoemann, N. Beaulieu et al., Two distinct Notch1 mutant alleles are involved in the induction of T-cell leukemia in cmyc transgenic mice, Mol Cell Biol 20 (2000), 3831-3842.
41. B.J. Feldman, T. Hampton et al., A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2A PBX1 transgenic mice, Blood 96 (2000), 1906-1913.
42. N. Gupta-Rossi, O. Le Bail et al., Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor, J Biol Chem 276 (2001), 34371-34378.
43. S.Y. Lee, K. Kumano et al., Mutations of the Notch1 gene in T-cell acute lymphoblastic leukemia: analysis in adults and children, Leukemia 19 (2005), 1841-1843.
44. B.J. Thompson, S. Buonamici et al., The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia, J Exp Med 204 (2007), 1825-1835.
45. R.S. Maser, B. Choudhury et al., Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers, Nature 447 (2007), 966-971.
46. F. Speleman, B. Cauwelier et al., A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 andHOXA11 in a subset of T-cell acute lymphoblastic leukemias, Leukemia 19 (2005), 358-366.
47. V.E. Valge-Archer, H. Osada et al., The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells, Proc Natl Acad Sci U S A 91 (1994), 8617-8621.
48. A.T. Look, Oncogenic transcription factors in the human acute leukemias, Science 278 (1997), 1059-1064.
49. T. Taghon, K. Thys et al., Homeobox gene expression profile in human hematopoietic multipotent stem cells and Tcell progenitors: implications for human T-cell development, Leukemia 17 (2003), 1157-1163.
50. V. Asnafi, A. Buzyn et al., NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study, Blood 113 (2009), 3918-3924.
51. M.J. Park, T. Taki et al., FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma, Br J Haematol 145 (2009), 198-206.
52. Y.M. Zhu, W.L. Zhao et al., NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis, Clin Cancer Res 12 (2006), 3043-3049.
53. M. van Grotel, J.P. Meijerink et al., Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences, Leukemia 22 (2008), 124-131.
54. M.R. Mansour, V. Duke et al., Notch-1 mutations are secondary events in some patients with T-cell acute lymphoblastic leukemia, Clin Cancer Res 13 (2007), 6964-6969.
55. M. Shih Ie and T.L.Wang, Notch signaling, gamma-secretase inhibitors, and cancer therapy, Cancer Res 67 (2007), 1879-1882.